期刊文献+

在与心肌的梗塞介绍的就医的病人的心率的预示的意义 被引量:3

Prognostic significance of heart rate in hospitalized patients presenting with myocardial infarction
下载PDF
导出
摘要 AIM: To investigate the prognostic significance of resting heart rate in patients with acute coronary syndrome (ACS), independent of other known factors. METHODS: Patients 40 years of age or older who had been admitted with acute coronary syndrome (ACS) to one of the 94 hospitals participating in the Prevalence of Peripheral Arterial Disease in Patients with Acute Coronary Syndrome (PAMISCA) study were included. Patients were divided into two groups based on their resting heart rate (HR ≥ or 【 70 bpm). Complications were recording during a follow-up period of 1 year. RESULTS: There were 1054 ACS patients analyzed (43.5% with ST segment elevation and 56.5% without elevation). Mean age was 66.6 ± 11.7 years, 70.6% were male and 29.4% of subjects were female. During follow-up, more patients in the HR ≥ 70 bpm group were hospitalized for heart failure and they also had a higher mortality rate. In the multivariate analysis, a heart rate of ≥ 70 bpm was independently related to overall mortality during the follow-up period (hazard ratio 2.5; 95% confidence interval, 1.26-4.97, P = 0.009). CONCLUSION: A resting heart rate ≥ 70 bpm in patients who survive an ACS is an indicator of a high risk of suffering cardiovascular events during follow-up. AIM: To investigate the prognostic significance of resting heart rate in patients with acute coronary syndrome (ACS), independent of other known factors. METHODS: Patients 40 years of age or older who had been admitted with acute coronary syndrome (ACS) to one of the 94 hospitals participating in the Prevalence of Peripheral Arterial Disease in Patients with Acute Coronary Syndrome (PAMISCA) study were included. Patients were divided into two groups based on their resting heart rate (HR ≥ or < 70 bpm). Complications were recording during a follow-up period of 1 year. RESULTS: There were 1054 ACS patients analyzed (43.5% with ST segment elevation and 56.5% without elevation). Mean age was 66.6 ± 11.7 years, 70.6% were male and 29.4% of subjects were female. During follow-up, more patients in the HR ≥ 70 bpm group were hospitalized for heart failure and they also had a higher mortality rate. In the multivariate analysis, a heart rate of ≥ 70 bpm was independently related to overall mortality during the follow-up period (hazard ratio 2.5; 95% confidence interval, 1.26-4.97, P = 0.009). CONCLUSION: A resting heart rate ≥ 70 bpm in patients who survive an ACS is an indicator of a high risk of suffering cardiovascular events during follow-up.
出处 《World Journal of Cardiology》 CAS 2012年第1期15-19,共5页 世界心脏病学杂志(英文版)(电子版)
关键词 HEART rate MYOCARDIAL INFARCTION PROGNOSIS Heart rate Myocardial infarction Prognosis
  • 相关文献

参考文献25

  • 1Alberto Dominguez-Rodriguez,Gabriela Blanco-Palacios,Pedro Abreu-Gonzalez.Increased heart rate and atherosclerosis: Potential implications of ivabradine therapy[J].World Journal of Cardiology,2011,3(4):101-104. 被引量:14
  • 2Kones R.Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refracto- ry angina, risk factor reduction, and revascularization. Vasc Health Risk Manag . 2010
  • 3Cucherat M,Borer JS.Reduction of Resting Heart Rate With Antianginal Drugs: Review and Meta-Analysis. American Journal of Therapeutics . 2011
  • 4Palatini P,Thijs L,Staessen JA,Fagard RH,Bulpitt CJ,Clem- ent DL,de Leeuw PW,Jaaskivi M,Leonetti G,Nachev C,O’’’’ Brien ET,Parati G,Rodicio JL,Roman E,Sarti C,Tuomilehto J.Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Archives of Internal Medicine . 2002
  • 5Kolloch R,Legler UF,Champion A,Cooper-Dehoff RM,Handberg E,Zhou Q,Pepine CJ.Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: ndings rom the INternational VErapamil SR/tran- dolapril STudy (INVEST). European Heart Journal . 2008
  • 6Fox K,Ford I,Steg PG,Tendera M,Robertson M,Ferrari R.Heart rate as a prognostic risk factor in patients with coro- nary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL) a subgroup analysis of a randomised con- trolled trial. The Lancet . 2008
  • 7Swedberg K,Komajda M,B hm M,Borer JS,Ford I,Dubost- Brama A,Lerebours G,Tavazzi L.Ivabradine and outcomes in chronic heart failure (SHIFT) a randomised placebo- controlled study. The Lancet . 2010
  • 8Mulder P,Barbier S,Chagraoui A,Richard V,Henry JP,Lallemand F,Renet S,Lerebours G,Mahlberg-Gaudin F,Thuillez C.Long-term heart rate reduction induced by the selective I (f) current inhibitor ivabradine improves left ven- tricular function and intrinsic myocardial structure in con- gestive heart failure. Circulation . 2004
  • 9Fang Y,Debunne M,Vercauteren M,Brakenhielm E,Richard V,Lallemand F,Henry JP,Mulder P,Thuillez C.Heart Rate Reduction Induced by the If Current Inhibitor Ivabradine Improves Diastolic Function and Attenuates Cardiac Tissue Hypoxia. Journal of Cardiovascular Pharmacology . 2011
  • 10Thackray SD,Ghosh JM,Wright GA,Witte KK,Nikitin NP,Kaye GC,Clark AL,Tweddel A,Cleland JG.The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers. American Heart Journal . 2006

二级参考文献32

  • 1Tardif JC,Ford I,Tendera M,Bourassa MG,Fox K.Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. European Heart Journal . 2005
  • 2Kannel WB,Kannel C,Paffenbarger RS,et al.Heart rate and cardiovascular mortality: the Framingham Study. American Heart Journal . 1987
  • 3Dyer AR,Persky V,Stamler J,et al.Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. American Journal of Epidemiology . 1980
  • 4Custodis F,Schirmer SH,Baumh kel M,Heusch G,B hm M,Laufs U.Vascular pathophysiology in response to increased heart rate. Journal of the American College of Cardiology . 2010
  • 5Giannoglou GD,Chatzizisis YS,Zamboulis C,Parcharidis GE,Mikhailidis DP,Louridas GE.Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. International Journal of Cardiology . 2008
  • 6Riccioni G.Ivabradine: recent and potential applications in clinical practice. Expert Opinion on Pharmacotherapy . 2011
  • 7Borer JS,Fox K,Jaillon P,Lerebours G.Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebocontrolled trial. Circulation . 2003
  • 8Singh BN.Morbidity and mortality in cardiovascular disorders: impact of reduced heart rate. Journal of Cardiovascular Pharmacology . 2001
  • 9Tardif JC.Heart rate as a treatable cardiovascular risk factor. British Medical Bulletin . 2009
  • 10Baumh kel M,Custodis F,Schlimmer N,Laufs U,B hm M.Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice. Atherosclerosis . 2010

共引文献14

同被引文献3

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部